| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1800034 | CMAB801注射液 | bevacizumab | Injection | Biological Products(2) | New Drug Application | 2018-04-13 | 泰州迈博太科药业有限公司 | Taizhou Maibotaike Pharmaceutical Co Ltd | In Review | 2018-04-12 | view |